Why the study?
Does statin therapy reduce the incidence of atrial fibrillation in patients at risk?
Does statin therapy reduce the incidence of atrial fibrillation in patients at risk?
Statin therapy may serve as an important adjunctive strategy for preventing new-onset and postoperative atrial fibrillation, though evidence is lacking for its use prior to electrical cardioversion.
Answers are grounded in this paper and cite their sources.
Supports statin consideration for new-onset and postoperative AF prevention; extends evidence base while leaving pre-cardioversion use unresolved.
The aim of the present systematic review is to present an overview of the evidence linking atrial fibrillation (AF), inflammation and oxidative stress, with emphasis on the potential of statins to decrease the incidence of different types of AF, including new-onset AF, after electrical cardioversion (EC) and after cardiac surgery. Observational and clinical trials have studied the impact of statin therapy on new-onset, post-EC or postoperative AF. Data from different observational trials have shown that treatment with statins significantly reduces the incidence of new-onset AF in the primary and secondary prevention. The data are insufficient to recommend the use of statins before EC. Finally, perioperative statin therapy may represent an important non-antiarrhythmic adjunctive therapeutic strategy for the prevention of postoperative AF.
No takes yet. Share an insight, caveat, or question.
Sánchez-Quiñones et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: